Fact CheckerSign in

NCT07192471Not yet recruitingPhase 1

A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma

Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Oct 2026

Status (registry)
Not yet recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
34 (estimated)
First submitted
8 Dec 2025
Start date
30 Oct 2026
Lead sponsor
Kyowa Kirin Inc.
NCT number
NCT07192471
EU CT number
2025-522523-96-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 34
  • 8 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Clinic de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainNot yet recruiting
Institut Catala D'oncologia
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainNot yet recruiting
Clinica Universidad de Navarra
Coordinator of this site? Confirm its status
MadridSpainNot yet recruiting
Clínica Universidad de navarra
Coordinator of this site? Confirm its status
PamplonaSpainNot yet recruiting
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
Coordinator of this site? Confirm its status
BergamoItalyNot yet recruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyNot yet recruiting
Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS
Coordinator of this site? Confirm its status
CandioloItalyNot yet recruiting
Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
Coordinator of this site? Confirm its status
TurinItalyNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.